V2X To Replace Avanos Medical In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Monday, July 27

8-K filing — AVANOS MEDICAL, INC. (AVNS)

Filed: 2026-07-22 AccNo: 0001606498-26-000096 Size: 233 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Avanos Medical And American Industrial Partners Obtain Required Regulatory Approvals For Pending Merger

8-K filing — V2X, Inc. (VVX)

Filed: 2026-08-10 AccNo: 0001628280-26-055284 Size: 3 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

V2X Announces $391M Base Value Contract, Up To $500M With All Options, From Marine Corps Logistics Command For Secondary Repairable Program Support

V2X Receives $87M U.S. Navy Order To Support F/A-18 Super Hornet, EA-18G Growler Aircraft

V2X, Inc. (NYSE: VVX) has been awarded an $87 million firm-fixed-price, indefinite-delivery/indefinite-quantity contract to enhance the performance, longevity, and mission readiness of SUU-79 pylons supporting F/A-18

Truist Securities Reiterates Hold on V2X, Raises Price Target to $85

Truist Securities analyst Tobey Sommer reiterates V2X (NYSE:VVX) with a Hold and raises the price target from $70 to $85.